Article
TRAIL receptor-induced features of epithelial-to-mesenchymal transition increase tumour phenotypic heterogeneity: potential cell survival mechanisms.
British journal of cancer - 1 Jan 2021
Peyre Ludovic, Meyer Mickael, Hofman Paul, Roux Jérémie
Abstract excerpt
The continuing efforts to exploit the death receptor agonists, such as the tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), for cancer therapy, have largely been impaired by the anti-apoptotic and pro-survival signalling pathways leading to drug resistance. Cell migration, invasion, differentiation, immune evasion and anoikis resistance are plastic processes sharing features of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
